Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Cancer Vaccines01:30

Cancer Vaccines

367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

CUL5-mediated ubiquitination in cancer cell therapy: context-dependent roles, molecular networks, and emerging therapeutic avenues.

Frontiers in medicine·2026
Same author

Malignant mesothelioma of the tunica vaginalis testis: A case report.

Oncology letters·2026
Same author

A natural product-hybridization approach toward anticancer drug discovery: synthesis and antitumor evaluation of CTBC6, designed from sulforaphane and magnolol.

Bioorganic chemistry·2026
Same author

Comparison of surgical outcomes between lateral and posterior methods for retroperitoneoscopic adrenalectomy: insights from a single center's experience.

Frontiers in oncology·2026
Same author

Effects of Florfenicol on Intestinal Structure, Microbial Community and Antibiotic Resistance Genes in <i>Penaeus vannamei</i>.

Microorganisms·2026
Same author

Case Report: A rare case of unilateral renal clear cell carcinoma with synchronous contralateral ureteral metastasis.

Frontiers in oncology·2026

相关实验视频

Updated: Jul 2, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.3K

膀癌:免疫疗法和盆腔淋巴结剖析

Zhongru Fan1, Junpeng Deng1, Yutao Wang2

  • 1Department of Urology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Nanjing 211166, China.

Vaccines
|February 24, 2024
PubMed
概括

免疫疗法为膀癌提供了一个有希望的,少毒的治疗方法. 然而,识别预测性生物标志物和了解盆腔淋巴结解剖的影响对于改善患者的治疗结果至关重要.

关键词:
膀癌:膀癌是一种癌症.免疫疗法 免疫疗法盆腔淋巴结解剖 盆腔淋巴结解剖

更多相关视频

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

12.5K
A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

14.8K

相关实验视频

Last Updated: Jul 2, 2025

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.3K
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

12.5K
A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

14.8K

科学领域:

  • 泌尿器科 泌尿器科 泌尿器科 泌尿器科
  • 在瘤学瘤学.
  • 免疫学 免疫学 免疫学

背景情况:

  • 膀癌是一种常见的恶性瘤,用辐射,化疗和手术治疗,这些都有限制和副作用.
  • 免疫疗法是一种新的方法,可以激活患者的免疫系统来对抗癌症,提供长时间的疗效和较少的有毒副作用.
  • 目前用于膀癌的免疫疗法包括免疫检查点抑制剂和癌症疫苗.

研究的目的:

  • 讨论免疫疗法在膀癌治疗中的挑战和潜力.
  • 突出了对免疫疗法疗效的预测生物标志物的需求.
  • 为了检查盆腔淋巴结解剖对免疫治疗结果的影响.

主要方法:

  • 审查目前用于膀癌的免疫疗法策略.
  • 讨论挑战,包括患者反应的变化以及盆腔淋巴结剖析的作用.
  • 对免疫检查点抑制剂和癌症疫苗的现有文献进行分析.

主要成果:

  • 免疫疗法的有效性在患者之间有很大差异,只有少数患者对免疫疗法有反应.
  • 盆腔淋巴结解剖可能会通过破坏免疫细胞来降低免疫疗法的疗效.
  • 预测性生物标志物对于优化免疫疗法选择和结果至关重要.

结论:

  • 免疫疗法在治疗膀癌症方面具有优势,包括降低毒性和持久反应.
  • 需要进一步的研究来确定预测生物标志物,并澄清盆腔淋巴结解剖的作用.
  • 考虑个体患者特征的个性化治疗策略是必要的,以最大限度地提高免疫治疗的益处.